Global Complement-dependent Cytotoxicity Testing Services Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Complement-dependent Cytotoxicity Testing Services Market Research Report 2024
Complement-dependent cytotoxicity assay (CDC) is an in vitro cell-based assay used to evaluate the cytotoxic ability of antibodies against target cells. CDC is based on the activation of the complement system and the formation of the membrane attack complex (MAC). In the CDC assay, target cells and antibodies are mixed, and then complement is added. Complement activation leads to the formation of MAC, resulting in the death of target cells. By measuring the survival rate of target cells or the release of molecules that represent cell death, the cytotoxic ability of the antibody can be evaluated. CDC is commonly used in the research and development of antibody drugs, vaccines, and immunotherapies, as well as in the evaluation of the efficacy of these treatments.
According to MRAResearch’s new survey, global Complement-dependent Cytotoxicity Testing Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Complement-dependent Cytotoxicity Testing Services market research.
Key companies engaged in the Complement-dependent Cytotoxicity Testing Services industry include Creative Biolabs, iQ Biosciences, Horizon Discovery, Sino Biological, Inc., GenScript ProBio, Agilent and Sartorius, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Complement-dependent Cytotoxicity Testing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Complement-dependent Cytotoxicity Testing Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Complement-dependent Cytotoxicity Testing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius
Segment by Type
Common Type
High Throughput Type
Biopharmaceuticals
Medical Diagnosis
Cell Engineering
Medical Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Complement-dependent Cytotoxicity Testing Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Complement-dependent Cytotoxicity Testing Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Complement-dependent Cytotoxicity Testing Services market research.
Key companies engaged in the Complement-dependent Cytotoxicity Testing Services industry include Creative Biolabs, iQ Biosciences, Horizon Discovery, Sino Biological, Inc., GenScript ProBio, Agilent and Sartorius, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Complement-dependent Cytotoxicity Testing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Complement-dependent Cytotoxicity Testing Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Complement-dependent Cytotoxicity Testing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius
Segment by Type
Common Type
High Throughput Type
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Cell Engineering
Medical Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Complement-dependent Cytotoxicity Testing Services report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source